TellBio
Andover, US · Founded 2019 · Delaware corporation
TellBio is a development-stage biotechnology company building the TellDx CTC System, a microfluidic diagnostic platform that isolates and detects circulating tumor cells (CTCs) to detect and monitor cancer progression, along with a therapeutics arm developing anti-cancer drugs based on CTC research. Its CTC isolation technology is exclusively licensed from Massachusetts General Hospital and is deployed as a research tool at centers of excellence.
BiotechHealthtechMedical Devices
Founders & leadership
PG
PRITESH GANDHIExecutive
Board
GC
GARY CROCKERBoard director
RP
Richard PetersBoard director
BP
BERNARD PETERSBoard director
Reported raises · per SEC filings
Form D private placements$11M disclosed across 5 rounds · 2019–2024
▶$1MraisedMar 2026 · 6 investors · BiotechnologyRule 506(b)
▶$1MraisedMar 2026 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GARY CROCKERDirector
- RICHARD PETERSExecutive Officer, Director
- BERNARD PETERSDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJul 2024 · 11 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJul 2024 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD PETERSDirector
- BERNARD PETERSDirector
- PRITESH GANDHIExecutive Officer, Director
- GARY CROCKERDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.3MraisedMar 2023 · 23 investors · BiotechnologyRule 506(b)
▶$2.3MraisedMar 2023 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PetersDirector
- Pritesh GandhiExecutive Officer, Director
- Gary CrockerDirector
- Bernard PetersDirector
- Offering amount
- $2.5M
- Amount sold
- $2.3M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5MraisedMar 2021 · 29 investors · BiotechnologyRule 506(b)
▶$5MraisedMar 2021 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PetersExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedOct 2019 · 19 investors · BiotechnologyRule 506(b)
▶$1.5MraisedOct 2019 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PetersExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapMission BioCapital Platinum Program Holdings LLC22 shared keywordsMission BioCapital is an early-stage venture capital firm that provides capital and shared lab space to life science startups, supporting founders from initial experiments through to the clinic. Founded in 2009, it invests in early-stage life science companies and is currently deploying its fifth fund.
GentiBio20 shared keywordsGentiBio develops engineered regulatory T-cell (EngTreg) therapies designed to reset the immune system and treat autoimmune and acute inflammatory diseases. The company builds autologous and allogeneic Treg platforms as an alternative to systemic immune-suppressive therapies.
Companies competing with TellBio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does TellBio do?
- TellBio is a development-stage biotechnology company building the TellDx CTC System, a microfluidic diagnostic platform that isolates and detects circulating tumor cells (CTCs) to detect and monitor cancer progression, along with a therapeutics arm developing anti-cancer drugs based on CTC research. Its CTC isolation technology is exclusively licensed from Massachusetts General Hospital and is deployed as a research tool at centers of excellence.
- How much funding has TellBio raised?
- TellBio has disclosed $11M raised across 5 rounds.
- Where is TellBio headquartered?
- TellBio is headquartered in Andover, US.